Global Market Study on Antibiotic Resistance: Approval & Launch of Novel Therapeutics Aiding Market Expansion

Feb 2021| PMR1586A| Persistence Market Research

Report Highlights

Antibiotic Resistance Market - Scope of Report

A latest publication by Persistence Market Research on the global antibiotic resistance market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on key market dynamics, which include the drivers, restraints, trends, and opportunities in the antibiotic resistance market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.

Important indicators for the successful growth of the antibiotic resistance market are presented in this comprehensive report, which include Year-on-Year (Y-o-Y) growth analysis of the market and compounded annual growth rate (CAGR), which are described in an exhaustive way in Persistence Market Research's study. This research study can support readers know the demand for antibiotic resistance products and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the antibiotic resistance space, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the market. Insights and wisdom presented in this Persistence Market Research study can be leveraged by shareholders in the antibiotic resistance market, industry experts, investors, researchers, reporters, as well as business enthusiasts.

Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the antibiotic resistance market are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this report, minor companies and new entrants in the antibiotic resistance industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research’s study on the antibiotic resistance market offers information divided into six important segments — drug class, pathogen, disease, mechanism of action, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics, and growth parameters associated with these categories.

Drug Class

  • Beta Lactam Antibiotics
  • Cephalosporin
  • Quinolones Antibiotics
  • Macrolide Antibiotics
  • Tetracycline
  • Oxazolidinones
  • Others

Pathogen

  • Staphylococcus aureus
  • Streptococcus pneumonia
  • Neisseria gonorrhoeae
  • Enterococcus faecium
  • Escherichia coli
  • Klebsiella Pneumonia
  • Shigella
  • Clostridium difficile
  • Others

Disease

  • Community Acquired Bacterial Pneumonia (CABP)
  • Hospital Acquired Bacterial Pneumonia/ Ventilator (HABP/VABP)
  • Complicated Urinary Tract Infections (CUTI)
  • Complicated Intra-Abdominal Infections (CIAI)
  • Blood Stream Infections (BSI)
  • Abdominal Infection and Diarrhoea (Clostridium difficile infections (CDI) & Shigella)
  • Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
  • Drug Resistant Gonorrhoeae

Mechanism of Action

  • Cell Wall Synthesis Inhibitors
  • Protein Synthesis Inhibitors
  • DNA Synthesis Inhibitors
  • RNA Synthesis Inhibitors
  • Others

Distribution Channel

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • MEA

Key Questions Answered in Report

  • Which regions will continue to remain the most profitable markets for antibiotic resistance?
  • Which parameters will bring a change in the demand for antibiotic resistance products during the forecast period?
  • How will changing trends impact the market?
  • How will the COVID-19 pandemic impact market growth?
  • How can market players capture the low-hanging opportunities in developed regions?
  • What are the winning strategies of stakeholders in the antibiotic resistance market to upscale their position in this landscape?
  • What are the restraints that investors need to be aware of and might tackle while investing in the market?
  • How can businesses in the antibiotic resistance market avail the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the antibiotic resistance market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the antibiotic resistance market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes Persistence Market Research’s projections on the growth prospects of the antibiotic resistance market more accurate and reliable.

  • Table 1 : Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Drug Class
  • Table 2 : Global Antibiotic Resistance Market Volume (Units) Analysis 2015-2019 and Forecast 2021- 2031, By Drug Class
  • Table 3 : Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Disease
  • Table 4 : Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Mechanism of action
  • Table 5 : Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Mechanism of action
  • Table 6 : Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Distribution Channel
  • Table 7 : Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, by Region
  • Table 8 : North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, by Country
  • Table 9 : North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Drug Class
  • Table 10 : North America Antibiotic Resistance Market Volume (Units) Analysis 2015-2019 and Forecast 2021- 2031, By Drug Class
  • Table 11 : North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Disease
  • Table 12 : North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Mechanism of action
  • Table 13 : North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Mechanism of action
  • Table 14 : North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Distribution Channel
  • Table 15 : Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, by Country
  • Table 16 : Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Drug Class
  • Table 17 : Latin America Antibiotic Resistance Market Volume (Units) Analysis 2015-2019 and Forecast 2021- 2031, By Drug Class
  • Table 18 : Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Disease
  • Table 19 : Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Mechanism of action
  • Table 20 : Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Mechanism of action
  • Table 21 : Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Distribution Channel
  • Table 22 : Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, by Country
  • Table 23 : Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Drug Class
  • Table 24 : Europe Antibiotic Resistance Market Volume (Units) Analysis 2015-2019 and Forecast 2021- 2031, By Drug Class
  • Table 25 : Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Disease
  • Table 26 : Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Mechanism of action
  • Table 27 : Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Mechanism of action
  • Table 28 : Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Distribution Channel
  • Table 29 : South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, by Country
  • Table 30 : South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Drug Class
  • Table 31 : South Asia Antibiotic Resistance Market Volume (Units) Analysis 2015-2019 and Forecast 2021- 2031, By Drug Class
  • Table 32 : South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Disease
  • Table 33 : South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Mechanism of action
  • Table 34 : South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Mechanism of action
  • Table 35 : South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Distribution Channel
  • Table 36 : East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, by Country
  • Table 37 : East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Drug Class
  • Table 38 : East Asia Antibiotic Resistance Market Volume (Units) Analysis 2015-2019 and Forecast 2021- 2031, By Drug Class
  • Table 39 : East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Disease
  • Table 40 : East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Mechanism of action
  • Table 41 : East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Mechanism of action
  • Table 42 : East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Distribution Channel
  • Table 43 : Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, by Country
  • Table 44 : Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Drug Class
  • Table 45 : Oceania Antibiotic Resistance Market Volume (Units) Analysis 2015-2019 and Forecast 2021- 2031, By Drug Class
  • Table 46 : Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Disease
  • Table 47 : Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Mechanism of action
  • Table 48 : Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Mechanism of action
  • Table 49 : Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Distribution Channel
  • Table 50 : MEA Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, by Country
  • Table 51 : MEA Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Drug Class
  • Table 52 : MEA Antibiotic Resistance Market Volume (Units) Analysis 2015-2019 and Forecast 2021- 2031, By Drug Class
  • Table 53 : MEA Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Disease
  • Table 54 : MEA Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Mechanism of action
  • Table 55 : MEA Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Mechanism of action
  • Table 56 : MEA Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2021- 2031, By Distribution Channel
  • Figure 1 : Global Antibiotic Resistance Market Volume (Mn Units) Analysis 2016-2020
  • Figure 2 : Global Antibiotic Resistance Market Volume (Mn Units) Analysis and Forecast 2021-2031
  • Figure 3 : Beta Lactam Antibiotic Pricing Analysis (US$) for Per Unit, By Region, 2020
  • Figure 4 : Cephalosporin Pricing Analysis (US$) for Per Unit, By Region, 2020
  • Figure 5 : Quinolones Antibiotic Pricing Analysis (US$) for Per Unit, By Region, 2020
  • Figure 6 : Macrolide Antibiotic Pricing Analysis (US$) for Per Unit, By Region, 2020
  • Figure 7 : Tetracycline Pricing Analysis (US$) for Per Unit, By Region, 2020
  • Figure 8 : Oxazolidinones plate Pricing Analysis (US$) for Per Unit, By Others, 2020
  • Figure 9 : Others Pricing Analysis (US$) for Per Unit, By Region, 2020
  • Figure 10 : Global Antibiotic Resistance Market Value (US$ Mn), 2016 - 2020
  • Figure 11 : Global Antibiotic Resistance Market Value Analysis and Forecast 2021 - 2031 (US$ Mn)
  • Figure 12 : Global Antibiotic Resistance Market Absolute $ Opportunity (US$ Mn), 2020-2031
  • Figure 13 : Global Antibiotic Resistance Market Share Analysis (%) By Drug Class, 2021 & 2031
  • Figure 14 : Global Antibiotic Resistance Market Y-o-Y Growth (%) By Drug Class, 2021-2031
  • Figure 15 : Global Antibiotic Resistance Market Attractiveness Analysis, By Drug Class, 2021- 2031
  • Figure 16 : Global Antibiotic Resistance Market Share Analysis (%) By Pathogen 2021 & 2031
  • Figure 17 : Global Antibiotic Resistance Market Y-o-Y Growth (%) By Pathogen, 2021-2031
  • Figure 18 : Global Antibiotic Resistance Market Attractiveness Analysis, By Pathogen, 2021- 2031
  • Figure 19 : Global Antibiotic Resistance Market Share Analysis (%) By Disease, 2021 & 2031
  • Figure 20 : Global Antibiotic Resistance Market Y-o-Y Growth (%) By Disease, 2021- 2031
  • Figure 21 : Global Antibiotic Resistance Market Attractiveness Analysis, By Disease, 2021- 2031
  • Figure 22 : Global Antibiotic Resistance Market Share Analysis (%) By Mechanism of action, 2021 & 2031
  • Figure 23 : Global Antibiotic Resistance Market Y-o-Y Growth (%) By Mechanism of action, 2021-2031
  • Figure 24 : Global Antibiotic Resistance Market Attractiveness Analysis, By Mechanism of action, 2021- 2031
  • Figure 25 : Global Antibiotic Resistance Market Share Analysis (%) By Distribution Channel, 2021 & 2031
  • Figure 26 : Global Antibiotic Resistance Market Y-o-Y Growth (%) By Distribution Channel, 2021-2031
  • Figure 27 : Global Antibiotic Resistance Market Attractiveness Analysis, By Distribution Channel, 2021- 2031
  • Figure 28 : Global Antibiotic Resistance Market Share Analysis (%) By Region, 2021 & 2031
  • Figure 29 : Global Antibiotic Resistance Market Y-o-Y Growth (%) By Region, 2021-2031
  • Figure 30 : Global Antibiotic Resistance Market Attractiveness Analysis, By Region, 2021- 2031
  • Figure 31 : North America Antibiotic Resistance Market Value Share, By Country 2021 (E)
  • Figure 32 : North America Antibiotic Resistance Market Value Share, By Drug Class 2021 (E)
  • Figure 33 : North America Antibiotic Resistance Market Value Share, By Pathogen 2021 (E)
  • Figure 34 : North America Antibiotic Resistance Market Value Share, By Disease 2021 (E)
  • Figure 35 : North America Antibiotic Resistance Market Value Share, By Mechanism of action 2021 (E)
  • Figure 36 : North America Antibiotic Resistance Market Value Share, By Distribution Channel (E)
  • Figure 37 : North America Antibiotic Resistance Market Value (US$ Mn), 2016 - 2020
  • Figure 38 : North America Antibiotic Resistance Market Value (US$ Mn) Forecast, 2021- 2031
  • Figure 39 : North America Antibiotic Resistance Market Value (US$ Mn) Forecast, 2021- 2031
  • Figure 40 : North America Antibiotic Resistance Market Attractiveness Analysis, By Drug Class, 2021- 2031
  • Figure 41 : North America Antibiotic Resistance Market Attractiveness Analysis, By Disease, 2021- 2031
  • Figure 42 : North America Antibiotic Resistance Market Attractiveness Analysis, By Mechanism of action, 2021- 2031
  • Figure 43 : North America Antibiotic Resistance Market Attractiveness Analysis, By Mechanism of action, 2021- 2031
  • Figure 44 : North America Antibiotic Resistance Market Attractiveness Analysis, By Distribution Channel, 2021- 2031
  • Figure 45 : North America Antibiotic Resistance Market Attractiveness Analysis, By Country, 2021- 2031
  • Figure 46 : Latin America Antibiotic Resistance Market Value Share, By Country 2021 (E)
  • Figure 47 : Latin America Antibiotic Resistance Market Value Share, By Drug Class 2021 (E)
  • Figure 48 : Latin America Antibiotic Resistance Market Value Share, By Pathogen 2021 (E)
  • Figure 49 : Latin America Antibiotic Resistance Market Value Share, By Disease 2021 (E)
  • Figure 50 : Latin America Antibiotic Resistance Market Value Share, By Mechanism of action 2021 (E)
  • Figure 51 : Latin America Antibiotic Resistance Market Value Share, By Distribution Channel (E)
  • Figure 52 : Latin America Antibiotic Resistance Market Value (US$ Mn), 2016 - 2020
  • Figure 53 : Latin America Antibiotic Resistance Market Value (US$ Mn) Forecast, 2021- 2031
  • Figure 54 : Latin America Antibiotic Resistance Market Attractiveness Analysis, By Drug Class, 2021- 2031
  • Figure 55 : Latin America Antibiotic Resistance Market Attractiveness Analysis, By Disease, 2021- 2031
  • Figure 56 : Latin America Antibiotic Resistance Market Attractiveness Analysis, By Mechanism of action, 2021- 2031
  • Figure 57 : Latin America Antibiotic Resistance Market Attractiveness Analysis, By Mechanism of action, 2021- 2031
  • Figure 58 : Latin America Antibiotic Resistance Market Attractiveness Analysis, By Distribution Channel, 2021- 2031
  • Figure 59 : Latin America Antibiotic Resistance Market Attractiveness Analysis by Country, 2021- 2031
  • Figure 60 : Europe Antibiotic Resistance Market Value Share, By Country
  • Figure 61 : Europe Antibiotic Resistance Market Value Share, By Drug Class 2021 (E)
  • Figure 62 : Europe Antibiotic Resistance Market Value Share, By Pathogen 2021 (E)
  • Figure 63 : Europe Antibiotic Resistance Market Value Share, By Disease 2021 (E)
  • Figure 64 : Europe Antibiotic Resistance Market Value Share, By Mechanism of action 2021 (E)
  • Figure 65 : Europe Antibiotic Resistance Market Value Share, By Distribution Channel 2021 (E)
  • Figure 66 : Europe Antibiotic Resistance Market Value (US$ Mn), 2016 - 2020
  • Figure 67 : Europe Antibiotic Resistance Market Value (US$ Mn) Forecast, 2021- 2031
  • Figure 68 : Europe Antibiotic Resistance Market Attractiveness Analysis by Country, 2021- 2031
  • Figure 69 : Europe Antibiotic Resistance Market Attractiveness Analysis, By Drug Class, 2021- 2031
  • Figure 70 : Europe Antibiotic Resistance Market Attractiveness Analysis, By Disease, 2021- 2031
  • Figure 71 : Europe Antibiotic Resistance Market Attractiveness Analysis, By Mechanism of action, 2021- 2031
  • Figure 72 : Europe Antibiotic Resistance Market Attractiveness Analysis, By Distribution Channel, 2021- 2031
  • Figure 73 : South Asia Antibiotic Resistance Market Value Share, By Country 2021 (E)
  • Figure 74 : South Asia Antibiotic Resistance Market Value (US$ Mn), 2016 - 2020
  • Figure 75 : South Asia Antibiotic Resistance Market Value Share, By Drug Class 2021 (E)
  • Figure 76 : South Asia Antibiotic Resistance Market Value Share, By Pathogen 2021 (E)
  • Figure 77 : South Asia Antibiotic Resistance Market Value Share, By Disease 2021 (E)
  • Figure 78 : South Asia Antibiotic Resistance Market Value Share, By Mechanism of action 2021 (E)
  • Figure 79 : South Asia Antibiotic Resistance Market Value Share, By Distribution Channel 2021 (E)
  • Figure 80 : South Asia Antibiotic Resistance Market Value (US$ Mn) 2016-2020
  • Figure 81 : South Asia Antibiotic Resistance Market Value (US$ Mn) Forecast, 2021- 2031
  • Figure 82 : South Asia Antibiotic Resistance Market Attractiveness Analysis by Country, 2021- 2031
  • Figure 83 : South Asia Antibiotic Resistance Market Attractiveness Analysis, By Drug Class, 2021- 2031
  • Figure 84 : South Asia Antibiotic Resistance Market Attractiveness Analysis, By Disease, 2021- 2031
  • Figure 85 : South Asia Antibiotic Resistance Market Attractiveness Analysis, By Mechanism of action, 2021- 2031
  • Figure 86 : South Asia Antibiotic Resistance Market Attractiveness Analysis, By Mechanism of action, 2021- 2031
  • Figure 87 : South Asia Antibiotic Resistance Market Attractiveness Analysis, By Distribution Channel, 2021- 2031
  • Figure 88 : East Asia Antibiotic Resistance Market Value Share, By Country 2021 (E)
  • Figure 89 : East Asia Antibiotic Resistance Market Value Share, By Drug Class 2021 (E)
  • Figure 90 : East Asia Antibiotic Resistance Market Value Share, By Pathogen 2021 (E)
  • Figure 91 : East Asia Antibiotic Resistance Market Value Share, By Disease 2021 (E)
  • Figure 92 : East Asia Antibiotic Resistance Market Value Share, By Mechanism of action 2021 (E)
  • Figure 93 : East Asia Antibiotic Resistance Market Value Share, By Distribution Channel 2021 (E)
  • Figure 94 : East Asia Antibiotic Resistance Market Value (US$ Mn), 2016 - 2020
  • Figure 95 : East Asia Antibiotic Resistance Market Value (US$ Mn) Forecast, 2021- 2031
  • Figure 96 : East Asia Antibiotic Resistance Market Attractiveness Analysis by Country, 2021- 2031
  • Figure 97 : East Asia Antibiotic Resistance Market Attractiveness Analysis, By Drug Class, 2021- 2031
  • Figure 98 : East Asia Antibiotic Resistance Market Attractiveness Analysis, By Disease, 2021- 2031
  • Figure 99 : East Asia Antibiotic Resistance Market Attractiveness Analysis, By Mechanism of action, 2021- 2031
  • Figure 100 : East Asia Antibiotic Resistance Market Attractiveness Analysis By Distribution Channel, 2021- 2031
  • Figure 101 : Oceania Antibiotic Resistance Market Value Share, By Country 2021 (E)
  • Figure 102 : Oceania Antibiotic Resistance Market Value Share, By Drug Class 2021 (E)
  • Figure 103 : Oceania Antibiotic Resistance Market Value Share, By Pathogen 2021 (E)
  • Figure 104 : Oceania Antibiotic Resistance Market Value Share, By Disease 2021 (E)
  • Figure 105 : Oceania Antibiotic Resistance Market Value Share, By Mechanism of action 2021 (E)
  • Figure 106 : Oceania Antibiotic Resistance Market Value Share, By Distribution Channel 2021 (E)
  • Figure 107 : Oceania Antibiotic Resistance Market Value (US$ Mn), 2016 - 2020
  • Figure 108 : Oceania Antibiotic Resistance Market Value (US$ Mn) Forecast, 2021- 2031
  • Figure 109 : Oceania Antibiotic Resistance Market Attractiveness Analysis by Country, 2021- 2031
  • Figure 110 : Oceania Antibiotic Resistance Market Attractiveness Analysis By Drug Class, 2021- 2031
  • Figure 111 : Oceania Antibiotic Resistance Market Attractiveness Analysis By Disease, 2021- 2031
  • Figure 112 : Oceania Antibiotic Resistance Market Attractiveness Analysis By Mechanism of action, 2021- 2031
  • Figure 113 : Oceania Antibiotic Resistance Market Attractiveness Analysis By Mechanism of action, 2021- 2031
  • Figure 114 : Oceania Antibiotic Resistance Market Attractiveness Analysis By Distribution Channel, 2021- 2031
  • Figure 115 : MEA Antibiotic Resistance Market Value Share, By Country 2021 (E)
  • Figure 116 : MEA Antibiotic Resistance Market Value Share, By Drug Class 2021 (E)
  • Figure 117 : MEA Antibiotic Resistance Market Value Share, By Pathogen 2021 (E)
  • Figure 118 : MEA Antibiotic Resistance Market Value Share, By Disease 2021 (E)
  • Figure 119 : MEA Antibiotic Resistance Market Value Share, By Mechanism of action 2021 (E)
  • Figure 120 : MEA Antibiotic Resistance Market Value Share, By Distribution Channel 2021 (E)
  • Figure 121 : MEA Antibiotic Resistance Market Value (US$ Mn), 2016 - 2020
  • Figure 122 : MEA Antibiotic Resistance Market Value (US$ Mn) Forecast, 2021- 2031
  • Figure 123 : MEA Antibiotic Resistance Market Attractiveness Analysis by Country, 2021- 2031
  • Figure 124 : MEA Antibiotic Resistance Market Attractiveness Analysis By Drug Class, 2021- 2031
  • Figure 125 : MEA Antibiotic Resistance Market Attractiveness Analysis By Disease, 2021- 2031
  • Figure 126 : MEA Antibiotic Resistance Market Attractiveness Analysis By Mechanism of action, 2021- 2031
  • Figure 127 : MEA Antibiotic Resistance Market Attractiveness Analysis By Mechanism of action, 2021- 2031
  • Figure 128 : MEA Antibiotic Resistance Market Attractiveness Analysis By Distribution Channel, 2021- 2031
  • Figure 129 : US. Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 130 : US. Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 131 : US. Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)
  • Figure 132 : US. Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 133 : US. Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 134 : Canada Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 135 : Canada Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 136 : Canada Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)
  • Figure 137 : Canada Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 138 : Canada Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 139 : Brazil Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 140 : Brazil Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 141 : Brazil Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)
  • Figure 142 : Brazil Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 143 : Brazil Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 144 : Mexico Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 145 : Mexico Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 146 : Mexico Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 147 : Mexico Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)
  • Figure 148 : Mexico Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 149 : Argentina Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 150 : Argentina Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 151 : Argentina Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)
  • Figure 152 : Argentina Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 153 : Argentina Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 154 : Germany Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 155 : Germany Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 156 : Germany Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 157 : Germany Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 158 : Germany Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 159 : Italy Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 160 : Italy Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 161 : Italy Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)
  • Figure 162 : Italy Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 163 : Italy Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 164 : France Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 165 : France Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 166 : France Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)
  • Figure 167 : France Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 168 : France Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 169 : U.K. Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 170 : U.K. Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 171 : U.K. Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)
  • Figure 172 : U.K. Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 173 : U.K. Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 174 : Spain Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 175 : Spain Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 176 : Spain Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)
  • Figure 177 : Spain Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 178 : Spain Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 179 : BENELUX Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 180 : BENELUX Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 181 : BENELUX Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)
  • Figure 182 : BENELUX Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 183 : BENELUX Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 184 : Russia Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 185 : Russia Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 186 : Russia Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)
  • Figure 187 : Russia Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 188 : Russia Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 189 : India Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 190 : India Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 191 : India Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)
  • Figure 192 : India Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 193 : India Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 194 : Thailand Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 195 : Thailand Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 196 : Thailand Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)
  • Figure 197 : Thailand Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 198 : Thailand Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 199 : Malaysia Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 200 : Malaysia Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 201 : Malaysia Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)
  • Figure 202 : Malaysia Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 203 : Malaysia Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 204 : China Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 205 : China Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 206 : China Antibiotic Resistance Market Value Share, By Pathogen, 2021 (E)
  • Figure 207 : China Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 208 : China Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 209 : Japan Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 210 : Japan Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 211 : Japan Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 212 : Japan Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 213 : Japan Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 214 : Australia Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 215 : Australia Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 216 : Australia Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 217 : Australia Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 218 : Australia Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 219 : New Zealand Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 220 : New Zealand Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 221 : New Zealand Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 222 : New Zealand Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 223 : New Zealand Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 224 : GCC Countries Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 225 : GCC Countries Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 226 : GCC Countries Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 227 : GCC Countries Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 228 : GCC Countries Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 229 : Turkey Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 230 : Turkey Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 231 : Turkey Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 232 : Turkey Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 233 : Turkey Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)
  • Figure 234 : South Africa Antibiotic Resistance Market Value Share, By Drug Class, 2021 (E)
  • Figure 235 : South Africa Antibiotic Resistance Market Value Share, By Disease, 2021 (E)
  • Figure 236 : South Africa Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 237 : South Africa Antibiotic Resistance Market Value Share, By Mechanism of action, 2021 (E)
  • Figure 238 : South Africa Antibiotic Resistance Market Value Share, By Distribution Channel, 2021 (E)

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organization of all sizes.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report